An ophthalmic composition comprising polyoxyethylene sorbitan Monooleate (80), Glycerin, Sodium CarboxyMethyl Cellulose, cross-linked polymer of boric acid, Acrylates / c10-30 alkyl acrylate, Castor Oil, Erythritol, levocarnitine, Sodium hydroxide and Water; and its use to treat, MIT Punish or prevent Dry Eye Syndrome.
The present invention relates to ophthalmic compositions and methods useful to treat dry eye, or to diagnose, cure, mitigate, treat, or prevent dry eye syndrome in man or other animals.LA SOLICITUD SE REFIERE A UNA COMPOSICIÓN OFTALMOLÓGICA QUE COMPRENDE MONOOLEATO DE POLIOXIETILENO(20) SORBITÁN, GLICERINA, CARBOXIMETILCELULOSA, ÁCIDO BÓRICO, POLÍMERO RETICULADO DE ACRILATOS/ACRILATO DE ALQUILOC10-30, ERITROL, LEVOCARNITINA, HIDRÓXIDO DE SODIO, AGUA Y ACEITE DE RICINO Y A SU USO EN EL TRATAMIENTO DIAGNOSTICO, PREVENCIÓN Y CURA DEL OJO SECO